NCCTG phase II trial of bevacizumab, gemcitabine, oxaliplatin in patients with metastatic pancreatic adenocarcinoma.

被引：0
|
作者：
Kim, G. P.
Oberg, A.
Kabat, B.
Sing, A.
Hedrick, E.
Campbell, D.
Alberts, S.
机构：
[1] N Cent Canc Treatment Grp, Rochester, MN USA
[2] Genentech Inc, San Francisco, CA 94080 USA
[3] SanofiAventis, Bridgewater, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4113
引用
收藏
页码：206S / 206S
页数：1
相关论文
共 50 条
  • [21] A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma
    Byeong-Bae Park
    Joon Oh Park
    Hyo Rak Lee
    Jeeyun Lee
    Dong Wook Choi
    Seong-Ho Choi
    Jin Seok Heo
    Jong Kyun Lee
    Kyu Taek Lee
    Do Hoon Lim
    Young Suk Park
    Ho-Yeong Lim
    Won Ki Kang
    Keunchil Park
    [J]. Cancer Chemotherapy and Pharmacology, 2007, 60 : 489 - 494
  • [22] A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma
    Park, Byeong-Bae
    Park, Joon Oh
    Lee, Hyo Rak
    Lee, Jeeyun
    Choi, Dong Wook
    Choi, Seong-Ho
    Heo, Jin Seok
    Lee, Jong Kyun
    Lee, Kyu Taek
    Lim, Do Hoon
    Park, Young Suk
    Lim, Ho-Yeong
    Kang, Won Ki
    Park, Keunchil
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (04) : 489 - 494
  • [23] Randomized, open-label, phase II trial of gemcitabine with or without bavituximab in patients with nonresectable stage IV pancreatic adenocarcinoma.
    Pandya, Shuchi Sumant
    Wong, Lucas
    Bullock, Andrea J.
    Grabelsky, Stephen A.
    Shum, Merrill Kingman
    Shan, Joseph
    Menander, Kerstin B.
    Reid, Tony R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] A phase II study of ipilimumab and nivolumab with radiation in metastatic pancreatic adenocarcinoma.
    Parikh, Aparna
    Wo, Jennifer Yon-Li
    Ryan, David P.
    Clark, Jeffrey W.
    Nipp, Ryan David
    Blaszkowsky, Lawrence Scott
    Weekes, Colin D.
    Van Seventer, Emily
    Ly, Leilana
    Foreman, Bronwen
    Corcoran, Ryan Bruce
    Hong, Theodore S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [25] Phase 1 trial of gemcitabine/nab-paclitaxel in combination with the autophagy inhibitor hydroxychloroquine in previously untreated patients with metastatic pancreatic adenocarcinoma.
    O'Hara, Mark H.
    Gallagher, Maryann
    Teitelbaum, Ursina R.
    Giantonio, Bruce J.
    Damjanov, Nevena
    Loaiza-Bonilla, Arturo
    Amaravadi, Ravi K.
    Heitjan, Daniel F.
    Vasilevskaya, Irina
    Von Hoff, Daniel D.
    Ramanathan, Ramesh K.
    Laheru, Dan
    De Jesus-Acosta, Ana
    Velculescu, Victor E.
    O'Dwyer, Peter J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [26] The combination of a chemotherapy doublet (gemcitabine and capecitabine) with a biological doublet (bevacizumab and erlotinib) in patients with advanced pancreatic adenocarcinoma. The results of a phase I/II study
    Watkins, D. J.
    Starling, N.
    Cunningham, D.
    Thomas, J.
    Webb, J.
    Brown, G.
    Barbachano, Y.
    Oates, J.
    Chau, I.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 (08) : 1422 - 1429
  • [27] Phase I/II trial of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma
    Weiss, Glen J.
    Waypa, Jordan
    Coats, Jessica
    Blaydorn, Lisa
    McGahey, Kayla
    Sangal, Ashish
    Whitehead, Robert P.
    Khemka, Vivek
    [J]. CANCER RESEARCH, 2017, 77
  • [28] GEMCITABINE, OXALIPLATIN AND CAPECITABINE (GEMOXEL) FOR PATIENTS WITH ADVANCED PANCREATIC ADENOCARCINOMA (APC). PRELIMINARY RESULTS OF AN ONGOING PHASE I/II TRIAL
    Hess, V.
    Pestalozzi, B.
    Ludwig, C.
    Winterhalder, R.
    Lohri, A.
    Jost, L.
    Widmer, L.
    Lee, L.
    Stillhart, P.
    Herrmann, R.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 181 - 181
  • [29] A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Carcinoma
    Chung, Elizabeth K.
    Posadas, Edwin M.
    Kasza, Kristen
    Karrison, Theodore
    Manchen, Elizabeth
    Hahn, Olwen M.
    Stadler, Walter M.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (02): : 150 - 154
  • [30] Gabrinox: A phase I-II of nab-paclitaxel plus gemcitabine followed by FOLFIRINOX in metastatic pancreatic adenocarcinoma.
    Assenat, Eric
    De La Fouchardiere, Christelle
    Mollevi, Caroline
    Samalin, Emmanuelle
    Portales, Fabienne
    Desseigne, Francoise
    Carenco, Christophe
    Dupuy, Marie
    Lopez-Martinez, Ernesto
    Fiess, Catherine
    Mazard, Thibault
    Ychou, Marc
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345